Study to Investigate Adherence of Patients to Clodronate (Bonefos) Treatment
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Breast Neoplasms|Prostatic Neoplasms|Multiple Myeloma|Osteolysis
Interventions: DRUG: Clodronate (Bonefos, BAY94-8393)
Sponsor: Bayer